SeekPeptides provides members with monitoring tools and tracking guidance specifically designed for GLP-1 users, making it easy to know whether your nutrition supports your weight loss goals or is quietly sabotaging them
Severe belly pain, ongoing vomiting, dehydration, weakness, numbness, or hair loss can be reasons to ask about testing
The favorable results from the placebo-controlled FLOW trial, conducted with semaglutide 1.0 mg in patients with T2D and chronic kidney disesase (CKD), are about to be disclosed, while ongoing dedicated trials will further explore the effects of OW semaglutide 2.4 mg (NCT04889183) and tirzepatide (NCT05536804) on kidney function parameters in obese/overweight individuals at high risk of CKD progression regardless of T2D
By acting on both the homeostatic (hunger-driven) and hedonic (pleasure-driven) aspects of eating, GLP-1 effectively recalibrates the brains perception of food
Both can prescribe GLP-1 receptor agonists through telehealth, and the compound itself drives the biological effect